Sales rose 12% to 13.44 billion euros on the continued strength of its anti-inflammatory drug Dupixent and sales in its pharma segment, which offset currency headwinds. Analysts expected business ...
Hindustan Unilever Ltd (HUL) announces the retirement of Dev Bajpai, Executive Director, Legal & Corporate Affairs, effective ...
US private equity firm Clayton Dubilier & Rice thought it had a deal to buy Sanofi’s consumer business. Losing bidder PAI ...
After a year-long takeover battle for the owner of France’s best-selling painkiller, Sanofi’s decision to sell its ...
A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...
Nigeria’s manufacturing sector is under siege. The cruel combination of high energy costs, foreign exchange scarcity, rising ...
K & R Rail Engineering, Ltd. saw a gain of almost 15% on Monday as a result of its shares rising from an intraday low of Rs ...
Sanofi on Sunday reached an agreement on terms to sell a controlling stake in its consumer health unit Opella to U.S. private ...
France will take a stake in Sanofi's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on ...
Sanofi and Orano join forces to develop next-generation radioligand medicines Paris, October 17, 2024. Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback